Search
for
Sort by
Research 151–180 of 1000+
- Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology
- Pattern of Skin disorders across age groups
- Impact of Consciousness Energy Healing Treatment on the Telogen Skin of Hair Follicles of C57BL/6 Mice
- Strengthening the Skin with Topical Delivery of Keratinocyte Growth Factor-1 Using a Novel DNA Plasmid
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Improvement of Hair Growth in Mouse Skin by Application of Consciousness Energy Treated Test Item
- Inverted Follicular Keratosis in Young Adult: A Rare Entity in the Differential Diagnosis of Skin Tumors
- Response to: “Rethinking biotin therapy for hair, nail, and skin disorders”
- ANNOUNCEMENTS
- Unraveling the Molecular Mechanisms of Hair and Nail Genodermatoses
- Differential diagnosis of hair loss in children. Differentialdiagnose des Haarausfalls bei Kindern
- Hair and Scalp Dermatoscopy (Trichoscopy)
- Contact dermatitis to phenol‐formaldehyde resin in two plywood factory workers
- Inherited Disorders of the Hair
- Histopathology of non-scarring alopecia
- Acquired Uncombable Hair
- Genetic Susceptibility to Alopecia
- Dermatological Manifestations of COVID-19: A Brief Review
- Mucocutaneous reactions to chemotherapy
- Keratin 17 null mice exhibit age- and strain-dependent alopecia
- Cutaneous lupus erythematosus
- Trichoscopy in Hair Shaft Disorders
- Black women’s hair: the main scalp dermatoses and aesthetic practices in women of African ethnicity
- Symmetrical alopecia in the dog
- Inconsolable Crying in Infants: Differential Diagnosis in the Pediatric Emergency Department
- Hair loss in infancy and childhood
- A method to improve the efficacy of topical eflornithine hydrochloride cream
- A CLINICAL STUDY OF MUCOCUTANEOUS MANIFESTATIONS OF HIV
- EFFICACY OF FLAXSEED CRACKERS IN AMELIORATING CLINICAL AND BIOCHEMICAL HYPERANDROGENISM IN YOUNG ADULT SOUTH INDIAN WOMEN DIAGNOSED WITH PCOS
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database